Obesity and adiponectin in acute myocardial infarction

Folia Cardiologica

Volumn 14, Issue 1, 2007, Pages 29-36

  Piestrzeniewicz, Katarzyna ^a   Łuczak, Katarzyna ^a   Komorowski, Jan ^a   Maciejewski, Marek ^a   Piechowiak, Monika ^a   Jankiewicz Wika, Joanna ^a   Goch, Jan Henryk ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Adiponectin; Myocardial infarction; Obesity

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; TRIACYLGLYCEROL; URIC ACID;

ACUTE HEART INFARCTION; ADULT; AGE; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY STENT; CORRELATION FUNCTION; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HIP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 34247489680     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kannel WE, Wilson PW, Nam BH, D'Agostino RE. Risk stratification of obesity as a coronary risk factor. Am J Cardiol, 2002; 90: 697-701.
2. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation, 1983; 67: 968-976.
3. Williams MJA, Williams SM, Milne BJ, Hancox RJ, Poulton R. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obes, 2004; 28: 998-1003.
4. Kumada M, Kihara S, Sumitsuji S et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol, 2003; 23: 85-89.
5. Dagenais GR, Yi Q, Mann JFE, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J, 2005; 149: 54-60.
6. Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. Body mass index. A risk factor for unstable angina and myocardial infarction in patients with angiographicany confirmed coronary artery disease. Circulation, 2003; 108: 2206-2211.
7. Rea TD, Heckbert SR, Kaplan RC. Body mass index and the risk of recurrent coronary events following acute myocardial infarction. Am J Cardiol, 2001; 88: 467-472.
8. Mattison R, Jensen M. The adipocyte as an endocrine cell. Curr Opin Endocrinol Diab, 2003; 10:317-321.
9. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab, 2004; 30: 13-19.
10. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem, 2004; 50: 1511-1525.
11. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 2004; 291: 1730-1737.
12. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999; 257: 79-83.
13. Hara T, Fujiwara H, Shoji T, Mimura T, Nakao H, Fujimoto S. Decreased plasma adiponectin levels in young obese males. J Atheroscler Thromb, 2003; 10: 234-248.
14. Hotta K, Funahashi T, Bodkin NL et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in paranel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes, 2001; 50: 1126-1133.
15. Yamamoto Y, Hirose H, Saito I et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci, 2002; 103: 137-142.
16. Cnop M, Havel PJ, Utzschneider DB et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 2003; 46: 459-469.
17. Ryo M, Nakamura T, Kihara S et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J, 2004; 68: 975-981.
18. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999; 100: 2473-2476.
19. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation, 2002; 105: 1135-1143.
20. Rothenbacher D, Brenner H, Marz W, Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J, 2005; 26: 1640-1646.
21. Nakamura Y, Shimada K, Fukuda D et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart, 2004; 90: 528-533.
22. Shimabukuro M, Higa N, Asahi T et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab, 2003; 88: 3236-3240.
23. Matsuda M, Shimomura I, Sata M et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem, 2002; 277: 37487-37491.
24. Shimada K, Miyauchi K, Mokuno H et al. Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting. Jpn Heart J, 2002; 43: 85-91.
25. Nishimura M, Hashimoto T, Kobayashi H. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemochalysis patients. Nephrol Dial Transplant, 2006; 21: 1640-1647.
26. Nishizawa H, Shimomura I, Kishida K et al. Androgens decrease plasma adiponectin, an insuline sensitizing adipocyte-derived protein. Diabetes, 2002; 51: 2734-2741.
27. Combs TP, Berg AH, Rajala MW et al. Sexual differentiation, pregnancy, caloric restriction, and aging affect the adipocite-specific secretory protein adiponectin. Diabetes, 2003; 52: 268-276.
28. Staiger H, Tschritter O, Machann J et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res, 2003; 11: 368-372.
29. Motoshima H, Wu X, Shima MK. Differential regulation of adiponectin secretion from cultured human omental and subcuteneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab, 2002; 87: 5662-5667.
30. Cote M, Mauriege P, Bergeron J et al. Adiponectinemia in visceral adiposity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab, 2005; 90: 1434-1439.
31. Yatagai T, Nagasaki S, Taniguchi A. Hipoadiponectinemia is associated with visceral fat accumulation and insuline resistance in Japanease men with type 2 diabetes mellitus. Metabolism, 2003; 52: 1274-1278.
32. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes, 2004; 28: 1018-1025.
33. Esmaillzadeh A, Mirmiran P, Azizi F. Waist-to-hip ratio is a better screening measure for cardiovascular risk factors than other anthropometric indicators in Tehranian adult men. Int J Obes, 2004; 28: 1325-1332.
34. Heinlein CA, Ting HJ, Yeh S, Chang C. Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma. J Biol Chem, 1999; 274: 16147-16152.
35. Baratta R, Amato S, Degano C et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab, 2004; 89: 2665-2671.
36. Shetty GK, Economides TA, Horton ES, Mantzordes CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care, 2004; 27: 2450-2457.
37. Tschritter O, Fritsche A, Thamer C et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes, 2003; 52: 239-243.
38. Torzewski M, Rist C, Mortensen RF. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in angiogenesis. Arterioscler Thromb Vasc Biol, 2000; 20: 2094-2099.
39. Kojima S, Funahashi T, Sakamoto T et al. The variation of plasma concentrations of novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart, 2003; 89: 667-668.
40. Ouchi N, Kihara S, Funahashi T et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation, 2003; 107: 671-674.
41. Okamaoto Y, Arita Y, Nishida M et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res, 2000; 32: 47-50.